Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear Cell Adenocarcinoma of Uterus”

97 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 97 results

Testing effectiveness (Phase 2)Study completedNCT00003127
What this trial is testing

S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

Who this might be right for
Endometrial Cancer
SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)Ended earlyNCT05949632
What this trial is testing

INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Incyte Corporation 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT00977574
What this trial is testing

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 349
Testing effectiveness (Phase 2)Looking for participantsNCT06023862
What this trial is testing

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more
Yonsei University 198
Large-scale testing (Phase 3)Study completedNCT01672892
What this trial is testing

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer

Who this might be right for
Cervical CancerEndometrial CancerGastrointestinal Complications+4 more
Radiation Therapy Oncology Group 289
Testing effectiveness (Phase 2)Active Not RecruitingNCT03348631
What this trial is testing

Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer

Who this might be right for
Recurrent Endometrial Endometrioid AdenocarcinomaRecurrent Malignant Uterine Corpus NeoplasmRecurrent Ovarian Carcinoma+2 more
National Cancer Institute (NCI) 62
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00575952
What this trial is testing

Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer

Who this might be right for
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+8 more
Gynecologic Oncology Group 27
Not applicableUnknownNCT01150682
What this trial is testing

Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group 865
Not applicableLooking for participantsNCT07557225
What this trial is testing

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Urothelial Carcinoma (UC)Colorectal Cancer+11 more
Peking University First Hospital 200
Large-scale testing (Phase 3)UnknownNCT00942357
What this trial is testing

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaStage IA Uterine Corpus Cancer AJCC v7+6 more
Gynecologic Oncology Group 813
Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Early research (Phase 1)Study completedNCT00005830
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+2 more
Gynecologic Oncology Group 31
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Study completedNCT01011933
What this trial is testing

Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+1 more
National Cancer Institute (NCI) 54
Early research (Phase 1)Looking for participantsNCT05542407
What this trial is testing

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Who this might be right for
Endometrial CancerMetastasisEndometrioid Endometrial Cancer+5 more
UNC Lineberger Comprehensive Cancer Center 58
Early research (Phase 1)Looking for participantsNCT05856981
What this trial is testing

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultMetastatic Solid TumorRefractory Cancer+4 more
Sairopa B.V. 130
Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT02059265
What this trial is testing

Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaOvarian Clear Cell CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+3 more
National Cancer Institute (NCI) 35
Next Page